This site is intended for a global audience
Contact Us

Leader Perspectives

Mat Davis

Recently, Mat Davis, PhD, vice president and head of data science, presented at the 2023 STAT Summit where he shared a key moment in his career when he learned the necessity of breaking down silos to fully embrace quantitative experts across the three avenues of drug development.

Dr. Logan Schneider and Dr. Kelvin Tan

As World Heart Day approaches, we are reminded of people who live with complex sleep disorders and how we can adequately address their unique needs. Learn more about the importance of thinking holistically about narcolepsy and idiopathic hypersomnia patients’ health from Jazz’s Dr. Kelvin Tan and Dr. Logan Schneider of the Stanford University School of Medicine.

Abizer Gaslightwala and Dr. Rachel Rau

Jazz’s oncology efforts are focused on delivering innovation to improve patient care, quality of life, and advancing scientific understanding of cancers with high unmet needs like acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL), which often affect children. To learn more about progress in the fight against these childhood blood cancers, Jazz’s Abizer Gaslightwala spoke with pediatric hematologist/oncologist Dr. Rachel Rau.

Kelvin Tan, MB BCh, MRCPCH, Senior Vice President and Chief Medical Officer

As a leader in sleep medicine, Jazz’s nearly 20-year leadership has been built around tackling rare sleep conditions, all while centering on and giving a voice to the patient and caregiver experiences, such as those living with idiopathic hypersomnia. Read more about our plans to expand and spotlight the I Have IH awareness campaign at SLEEP 2023. 

Kim Sablich, Executive Vice President and General Manager, US

For nearly 20 years, Jazz Pharmaceuticals has been a leader in sleep medicine. At SLEEP 2023, we reflect on our key learnings from the past two decades and reaffirm our longstanding commitment to the sleep community.

Rob Iannone, Executive Vice President, Global Head of Research and Development

As both ASCO and SLEEP kick off this weekend, we are excited to meet with thought leaders and advocates across the oncology and sleep communities. By applying our pioneering approach and deep expertise in sleep disorders and oncology, we are working hard to advance industry-leading research and development so we can deliver new potential therapies to help even more patients.